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Abstract 
Chronic health effects are increasing in the world such as cancers, hormonal, reproductive, 
nervous, or immune diseases, even in young people. During regulatory toxicological sub-
chronic tests to prevent these on mammalian health, prior commercialization of chemicals, 
including pesticides and drugs, or GMOs, some statistically significant findings may be re-
vealed. This discussion is about the need to investigate the relevant criteria to consider 
those as biologically significant. The sex differences and the non linear dose or time related 
effects should be considered in contrast to the claims of a Monsanto-supported expert panel 
about a GMO, the MON 863 Bt maize, but also for pesticides or drugs, in particular to re-
veal hormone-dependent diseases and first signs of toxicities. 
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Introduction 
Some contaminations or pollutions by pesticides 
[1] and other chemical residues [2-4] affect human and 
animal health, together with biodiversity. Thus it is 
important to study potential mid and long-term toxi-
cological effects during regulatory tests prior to 
commercialization of chemicals, and not to test only 
short-term or subchronic effects. This question has 
also been raised for GMOs [5], especially those con-
taining pesticides, either because they tolerate (such 
as Roundup Ready soya) or produce (such as Bt 
maize) these molecules (99 % of commercially culti-
vated GMOs). This subject has been reviewed recently 
by Dronamraju [6]. 
Objectives 
Here we shall discuss more particularly the ex-
isting data on possible toxic effects of a GMO on 
mammals, with putative relevance to humans, and 
with the aim of commenting on current procedures 
and experimental protocols in mammalian feeding 
experiments (Fig. 1).  Doull et al. [7] indicated their 
general criteria needed to classify as biologically 
relevant the observed significant effects during 90d 
toxicological tests on mammals. The example taken 
was for a GMO, a Bt maize called MON 863, produc-
ing in its cells a new kind of modified insecticide 
Cry3Bb1, known as a toxin for coleopterans. But these Int. J. Biol. Sci. 2009, 5 
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authors claim to apply the same criteria to other 
products such as pesticides and drugs. The history of 
the debate on the biosafety of this GMO is paradig-
matic, and it raises a series of general questions on 
risk assessment of commercial transgenic crops and of 
pesticides or chemicals. These considerations are cru-
cial, since public health is concerned and their discus-
sion may critically influence the decision to release in 
particular some agricultural GMOs or not, and also to 
another extent the economic feasibility of this kind of 
project. 
 
 
Figure 1. Comparison of regulatory toxicity tests generally performed in vivo on mammals, for instance with rats, the most 
used model, before commercialization of various products. These are GMOs used for food or feed, pesticides, drugs, or the 
best tested chemicals. The choice of how to apply standards is made by scientific commissions of regulatory instances. This 
figure does not include reproductive, developmental or trans-generational tests that are not requested for commercialized 
GMOs for food or feed. Nutritional tests are not represented either because they do not require blood analyses, which are 
very informative on health secondary effects. Some mammalian nutritional tests are performed with pigs or cows, for 
instance for GMOs, and may last longer with fewer animals. Subchronic toxicity tests are in the last case performed, if any, 
only with rats for most GMOs. Then it is only with 10 animals fully assessed on 20 for each of two doses, and per sex. There 
are 3 mammalian species used for other products. This is to measure short-term effects. The so-called chronic tests (lasting 
more than 3 months) give more chances to reveal metabolic, nervous, immune, hormonal or cancer diseases. They are 
widely performed for pesticides and drugs and for some chemicals over a certain production, but not for actual commer-
cialized GMOs released in the environment (1995-2009). This is a matter of debate, since 99.9% of those are genetically 
modified to contain new pesticide residues that they tolerate (ex. Roundup Ready soya) or that they produce (ex. insec-
ticides Bt in maize, that are newly modified proteic toxins). (d: day; m: month; y: year). 
 
The protocol used to test GMOs in regulatory 
in vivo tests with mammals   
Recently, Doull et al. [7] offered a new contra-
dictory analysis of Séralini et al. [5]. It was about the 
interpretation of the only crude data available from 
the longest toxicity test (90 days) on a mammal that 
had been fed with MON 863. The original feeding 
experiment was performed by Covance and Mon-
santo [8], with a great experience of this kind of tests 
always designed in a similar manner. They measured 
the effect of feed containing only two doses (11 and 
33% GM in the equilibrated diet) and for only two 
periods of exposure (5 and 14 weeks). The goal is a 
debate on standards to be set to interpret admitted 
significant effects [7] between treated groups versus 
controls as biologically relevant or not in toxicological 
tests in general. 
There are several preliminary unsolved ques-
tions at stake to be answered such as whether to pro-
long tests before commercial release, for instance up 
to two years for GMOs, as is done for some pesticides 
or drugs, in order to assess chronic effects not visible 
in short periods. There are also questions regarding 
the appropriate number of concentrations of the pu-
tative toxic agent to be tested etc., and critical ex-Int. J. Biol. Sci. 2009, 5 
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perimental criteria such as number of animals to be 
used per dose or concentration to increase their reso-
lution power to obtain homogeneous and reliable 
significance levels in outcome measurement data. 
However, the crude data on MON 863 were ob-
tained by Monsanto for only one mammalian species 
(instead of the three used for evaluations of pesticides 
or drugs) and first classified as confidential by the 
Company which obtained it (2002). The data was then 
used to obtain commercial release agreements all over 
the world. After heated discussions in Europe con-
cerning the possible physiological effects provoked by 
this GMO, a decision in the German Appeal Court 
allowed public access to the crude data (2005). Mon-
santo then published its own interpretation of the 
data [8] in which it was concluded that the MON 863 
was safe to eat.   
After careful analysis of the crude data, Séralini 
et al. [5] applied appropriate statistical methodology 
to test the effects of the Bt maize on mammalian 
health. First, GM fed rats were compared to their 
closest isogenic controls, and then to the six reference 
groups who were fed various other maize-based diets 
that Monsanto added in the study. Data were com-
piled by organ, dose and timing of dietary exposure. 
In addition, the effects on the rat metabolism of the 
diet composition without GM maize was studied, 
comparing only control and reference groups between 
them to avoid systematically linking these effects to 
the GM diet. In the first instance Monsanto did not do 
such a statistical study ([8] and in commercial request 
file) but only took into account effects between the 
GM fed rats at the highest dose and all other groups. It 
is important to note that in order to isolate the effect of 
the GM transformation process from other variables it 
is only valid to compare the GMO (in this case MON 
863) with its isogenic non-GM equivalent. Therefore, 
the inclusion in the analysis of unrelated feeding 
groups serves to confuse rather than clarify the effect 
of the MON 863 event.  
The goal of the statistical analysis is to decide 
whether the consumption of GMOs can be considered 
to have no effect (null hypothesis H0 true) or to have 
an effect (H0 false) on the health of the rats. This 
analysis cannot be reduced in the computation of a 
collection of p-values. Statistical rejection of the null 
hypothesis H0 does not imply that the effect is bio-
logically significant. In the same way, failure to reject 
H0 does not mean that it is true. Therefore, the power 
of the hypothesis test must be assessed. The power of 
a statistical test depends on the sample size (and 
therefore the experimental design), the significance 
level of the test and the effect size (which can be con-
sidered as biologically significant). This most impor-
tant issue is totally overlooked in the experimental 
design and the statistical report made by Monsanto on 
MON 863. Moreover, any hypothesis which is not 
statistically significant with their reductive method is 
always excluded. This disturbing oversight runs false 
negative results and a risk of health consequences for 
millions of people and animals. 
Sex-related and non-linear signs of toxicity 
In the MON 863 study, Séralini et al. [5] were also 
concerned by false positive results, but concluded that 
there were enough signs of toxicity to prolong the 
feeding experiments. This is mostly because signifi-
cant effects were concentrated in livers and kidneys as 
main detoxification organs reacting in cases of food / 
chemical contamination; there were at these levels 
some worrying physiological profiles. Moreover, the 
effects of the MON 863 insecticide toxin itself are not 
experimentally documented on mammalian cells. 
Furthermore, it remains a possibility that there would 
be side effects due to insertional mutagenesis during 
the GM transformation. For instance, the Séralini et al. 
[5] analysis showed evidence of a significant increase 
in blood glucose of 10% in GM-fed females, in 
triglycerides of 24-40%, overweight livers and en-
hanced liver/brain ratios (7%), small but significant 
body weight gain (3.7%), and disturbed kidney pa-
rameters. When comparing females eating GMOs to 
their closest controls eating the isogenic line, there 
were signs of a possible pre-diabetic profile. In both 
sexes and periods the profiles were different but it 
concerned liver and kidney parameters.  
From that, Doull et al. [6] concluded that any ef-
fects with no clear dose-response relationship (which 
should increase with dose) or with time are unrelated 
to the GM diet. We consider that first of all, to a sci-
entific point of view, choosing a priori 2 doses and 2 
periods does not allow the assessment of a linear 
dose- or period-related effect [9-11]. Our hypothesis 
was to question the possibility of subchronic or 
chronic health effects that were not or only partially 
revealed by short-term tests. Several hormonal dis-
rupting effects do not linearly increase with time or 
dose, but present non-linear peaks in the shape of U 
or J curves [12-14] at some periods or some ranges of 
doses, depending on the age and exposure period of 
the test animals [15-17]. Secondly, a clear histopa-
thological study should be published and studied in 
parallel to the biochemical effects found by Monsanto 
or the Monsanto-supported expert panel [7]. It is pos-
sible that metabolic changes precede, within 90 days, 
histopathological lesions that could appear after-
wards. This is another reason to prolong the experi-
ments and may also solve the problem of reproduci-Int. J. Biol. Sci. 2009, 5 
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bility. Simultaneously, the occurrence of similar ef-
fects in both sexes is an important criterion of toxicity 
for Doull et al. [7], which is not for us. Sex-dependent 
differences in chronic diseases resulting from chemi-
cal intoxication are well established [18, 19]. The liver 
is itself a sex-differentiated organ; for example 
chemical sensitivity is different in males and females 
[20]. In Monsanto's data for these 3 month rat tests 
with Bt maize MON 863, for all rats including the six 
times bigger group of normal control and reference 
animals eating non GM diets, there were confirmed 
sex-differentiated effects in liver and kidneys pa-
rameters (Fig.2A and B). Doull et al. [7] also consid-
ered a normal range of variations in undefined his-
torical data, or compiled the closest isogenic control 
with other reference groups that have diets different 
in salt or sugars. This is not scientifically precise. 
 
 
Figure 2. A. Principal Component Analysis for liver parameters in all rats of the MON 863 experiment. It was performed 
according to Hotelling [29] in order to study the scattering of the different factors. The scheme obtained for parameters at 
week 14 explains 42.42% of the total data variability (inertia) expressed on 2 axes (32.01% for factor 1; 10.41% for factor 2), 
scale d=2. This demonstrates the clear separation of parameters values according to sex. B. Principal Component Analysis 
for kidney parameters in all rats of the MON 863 experiment. The scheme obtained for parameters at week 14 explains 
47.73% of the total data variability (inertia) expressed on 2 axes (26.95% for factor 1; 20.78% for factor 2), scale d=5. This 
demonstrates the clear separation of parameters values according to sex. Int. J. Biol. Sci. 2009, 5 
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Conclusion 
We assume that Séralini et al. [5] methodology 
can discriminate potential false positive and 
GM-linked effects, avoiding to some extent false 
negative ones, in the best way we can do for this dis-
cussed and too limited protocol already in use for 
commercialized GMOs. These GM-linked effects are 
then considered as signs of toxicity in the 90 days, not 
proofs of toxicity. The biological plausibility of a 
s u b c h r o n i c  o r  c h r o n i c  s i d e  e f f e c t  o f  t h e  G M  d i e t ,  
linked to the new toxin in the mammalian regimen, or 
due to the mutagenesis effect of the genetic modifica-
tion itself, is thus non negligible. Finally it should be 
stressed that statistically significant effects of GM di-
ets, or of residues of pesticides that are contained by 
GMOs, have also been observed in other instances 
[21-25], but not in all studies [26, 27] enlightening the 
necessity of a case-by-case approach, and that the real 
toxicological studies are quite limited up to date for 
that [28]. All these observations taken together in our 
opinions do not allow a clear statement of toxic ef-
fects, but to suggest them as such, because they are 
clearly undeniable. Now, to any good researcher 
similar results would mean that there is much to be 
improved in the planning of experimental design; and 
thus to increase their resolution power to obtain un-
equivocal statements, for instance increasing the du-
ration and/or the number of rats tested. Generally 
speaking it seems to us unbelievable that a risk as-
sessment carried out only on forty rats of each sex 
receiving GM rich diets for 90 days (yielding results 
often at the limits of significance) have not been re-
peated and prolonged independently. We should 
overall take into account the fact that the analysed 
GM product could be fed long-term to people and 
animals of various ages and sexes, and with various 
pathologies. 
We call for more serious standardized tests such 
as those used for pesticides or drugs, on at least three 
mammalian species tested for at least three months 
employing larger sample sizes, and up to one and two 
years before commercialization, for GM food or feed 
specifically modified to contain pesticide residues. We 
also call for a serious scientific debate about the crite-
ria for testing significant adverse health effects for 
pesticides or chemicals, but overall for GM food or 
feed products, such as MON 863. 
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